155 related articles for article (PubMed ID: 26267900)
1. An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.
Prevato M; Cozzi R; Pezzicoli A; Taddei AR; Ferlenghi I; Nandi A; Montomoli E; Settembre EC; Bertholet S; Bonci A; Legay F
PLoS One; 2015; 10(8):e0135383. PubMed ID: 26267900
[TBL] [Abstract][Full Text] [Related]
2. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
[TBL] [Abstract][Full Text] [Related]
3. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
[TBL] [Abstract][Full Text] [Related]
4. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
[TBL] [Abstract][Full Text] [Related]
5. Analyzing swine sera for functional antibody titers against influenza A neuraminidase proteins using an enzyme-linked lectin assay (ELLA).
Sandbulte MR; Eichelberger MC
Methods Mol Biol; 2014; 1161():337-45. PubMed ID: 24899442
[TBL] [Abstract][Full Text] [Related]
6. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
7. An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera.
Couzens L; Gao J; Westgeest K; Sandbulte M; Lugovtsev V; Fouchier R; Eichelberger M
J Virol Methods; 2014 Dec; 210():7-14. PubMed ID: 25233882
[TBL] [Abstract][Full Text] [Related]
8. Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.
Prevato M; Ferlenghi I; Bonci A; Uematsu Y; Anselmi G; Giusti F; Bertholet S; Legay F; Telford JL; Settembre EC; Maione D; Cozzi R
PLoS One; 2015; 10(8):e0135474. PubMed ID: 26280677
[TBL] [Abstract][Full Text] [Related]
9. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
[TBL] [Abstract][Full Text] [Related]
10. Assessment of influenza A neuraminidase (subtype N1) potency by ELISA.
Wan H; Sultana I; Couzens LK; Mindaye S; Eichelberger MC
J Virol Methods; 2017 Jun; 244():23-28. PubMed ID: 28257802
[TBL] [Abstract][Full Text] [Related]
11. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
[TBL] [Abstract][Full Text] [Related]
12. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Koga M; Adachi E; Kikuchi T; Wang IH; Yamada S; Kawaoka Y
Nat Microbiol; 2019 Jun; 4(6):1024-1034. PubMed ID: 30886361
[TBL] [Abstract][Full Text] [Related]
13. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
Zheng A; Sun W; Xiong X; Freyn AW; Peukes J; Strohmeier S; Nachbagauer R; Briggs JAG; Krammer F; Palese P
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493826
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
17. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets.
Chen Z; Kim L; Subbarao K; Jin H
Vaccine; 2012 Mar; 30(15):2516-22. PubMed ID: 22330124
[TBL] [Abstract][Full Text] [Related]
18. Detection and Titration of Influenza A Virus Neuraminidase Inhibiting (NAI) Antibodies Using an Enzyme-Linked Lectin Assay (ELLA).
Kaplan BS; Vincent AL
Methods Mol Biol; 2020; 2123():335-344. PubMed ID: 32170699
[TBL] [Abstract][Full Text] [Related]
19. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.
Eichelberger MC; Couzens L; Gao Y; Levine M; Katz J; Wagner R; Thompson CI; Höschler K; Laurie K; Bai T; Engelhardt OG; ; Wood J
Vaccine; 2016 Jan; 34(4):458-465. PubMed ID: 26707221
[TBL] [Abstract][Full Text] [Related]
20. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
